Filing Details

Accession Number:
0001237899-13-000032
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-09 16:59:35
Reporting Period:
2013-05-07
Filing Date:
2013-05-09
Accepted Time:
2013-05-09 16:59:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1391382 J Robert Terifay 777 Old Saw Mill River Road
Tarrytown NY 10591
Svp Commercial No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-07 14,750 $16.80 30,074 No 4 M Direct
Common Stock Disposition 2013-05-07 946 $261.67 29,128 No 4 F Direct
Common Stock Disposition 2013-05-07 6,857 $261.67 22,271 No 4 F Direct
Common Stock Acquisiton 2013-05-07 2,173 $16.80 24,444 No 4 M Direct
Common Stock Disposition 2013-05-07 139 $261.67 24,305 No 4 F Direct
Common Stock Disposition 2013-05-07 750 $261.67 23,555 No 4 F Direct
Common Stock Disposition 2013-05-08 3,394 $260.86 20,161 No 4 S Direct
Common Stock Disposition 2013-05-08 4,437 $261.44 15,724 No 4 S Direct
Common Stock Disposition 2013-05-08 400 $262.06 15,324 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-05-07 14,750 $0.00 14,750 $16.80
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-05-07 2,173 $0.00 2,173 $16.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,173 2011-12-31 2018-12-17 No 4 M Direct
0 2018-12-17 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,588 Indirect By 401(k) Plan
Footnotes
  1. Represents volume-weighted average price of sales of 3,394 shares of Company stock on May 8, 2013 at prices ranging from $260.58 to $260.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 8, 2013 at each separate price.
  2. Represents volume-weighted average price of sales of 4,437 shares of Company stock on May 8, 2013 at prices ranging from $261.01 to $261.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 8, 2013 at each separate price.
  3. Represents volume-weighted average price of sales of 400 shares of Company stock on May 8, 2013 at prices ranging from $262.03 to $262.13. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 8, 2013 at each separate price.
  4. On December 17, 2008, the reporting person was granted an option to purchase 48,750 shares of Common Stock. The option was eligible to vest, partially or in full, on December 31, 2011, based on the extent to which the company satisfied certain performance criteria. The performance criteria were met and the option vested as to all shares.
  5. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
  6. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.